Chapter 1063: Pharmaceutical surge

"Pick up an apocalyptic world (
As the protagonist of the celebration banquet, Liu Mingyu's toast can be imagined.
Ali Ma and Xiao Ma wanted to get Liu Mingyu drunk, but the end result was naturally that the two horses were rarely drunk, but Liu Mingyu was still full of energy.
Liu Mingyu, who has gone through three genetic evolutions and used points to strengthen himself to a peak state, how could he be afraid of a little alcohol.
With Liu Mingyu's current physical fitness, there is no alcohol that can infuse him.
The alcohol, after entering Liu Mingyu's body, was absorbed and became a kind of energy hidden in his body.
He now belongs to the real thousand cups and is not drunk.
In the beginning, it was only two horses and two people to persuade the wine. Later, when the people around saw Liu Mingyu so massive, they all participated.
The end result was that all the people around him became drunk. Fortunately, this was the hotel. Zhang Guoqing also took into account that some people might need accommodation, so he wrapped up the entire hotel so that they would not sleep on the street.
The next day.
Alima touched his headache head, recalling the scene yesterday, a trace of fear flashed in his heart, his alcohol volume was actually quite good, but facing Liu Mingyu who was as relaxed as drinking water, he couldn't help but shudder.
He swears that in this life, he will never take the initiative to find Liu Mingyu to drink, this guy is too good to drink.
Brother Xiao Ma didn't get any better, the first thing he did when he woke up was to vow not to drink with Liu Mingyu again.
In fact, it is not just the two of them. Many of the people who witnessed this battle last night couldn't help but shudder at the thought of that scene.
Liu Mingyu was very energetic, got up early in the morning, and after finishing the routine homework and brushing tasks, he went to the two horses to have breakfast.
Both horses are busy people. This time they were able to participate in the celebration banquet of Star Pharmaceutical because they happened to be nearby. After breakfast, they left in a hurry.
News of the sky-high auction is still hotly discussed on the Internet.
All the companies or individuals that won the bid put the money into the account of Star Pharma the next morning, for fear of being slower, they were kicked out by Star Pharma.
Zhang Guoqing informed Liu Mingyu this morning about Ito Pharmaceutical’s automatic price increase.
After Liu Mingyu heard this, he was also surprised for a while, and then relieved.
The other party didn't know that they had decided to supply them at the previously agreed price. They were forgiven for fear that Xingchen Pharmaceutical would go back and raise the price automatically.
In this regard, Xingchen Pharmaceutical takes the initiative.
Liu Mingyu naturally laughed at Ito Pharmaceutical's independent increase of agency fees.
Why don't the other party send money to himself? And this is the normal price, and the other party is not at a loss when giving this price.
Zhang Guoqing went through the formalities for them immediately.
In the afternoon, Murakami Nakaki, who received the notice, immediately rushed to Stars Pharmaceutical, holding the contract signed and sealed by both parties, and his hanging heart was let go.
Finally, there is an explanation.
For the next period of time, Star Pharma was busy signing contracts with various companies.
After signing the contract, Xingchen Pharmaceutical provided them with general cancer treatment as soon as possible.
Although the output of general-purpose cancer medicines is limited, there is no problem in giving them a little bit.
Compared with Huaxia, the international consumption is only less than 1% of the output, which has no major impact at all.
Most of the companies that can get general cancer treatment drugs right now are actually Asian yellow people, and people with other skin colors need to conduct clinical trials.
For the clinical trials of blacks and whites, Star Pharma did not break its promise.
Immediately conducted clinical trials on black and white people.
Naturally, this experiment does not need to be like before, a phase II and phase III clinical trial, the total number of cases exceeds 10,000.
According to the normal ratio, 100 people were selected for the experiment this time.
During the clinical trials, Star Pharma did not break its promise, and announced on its official website a joint trial with Pfizer.
It seems to be a joint experiment of the two companies, but in fact, everyone knows that the experiments are basically controlled by Xingchen Pharmaceutical.
For such an important drug, it is impossible for Xingchen Pharmaceutical to involve Pfizer Pharmaceuticals, even if they know that there is no raw stone, it is impossible for them to make a general cancer treatment.
Pfizer Pharmaceuticals also knows itself. Their purpose is not to really participate in the experiment, but to comfort those investors and shareholders with a quota of cooperation.
I don't know if they are really blind or blind on purpose.
After Star Pharma issued a statement, Pfizer's stock price, which had been cut in half, immediately jumped by nearly 20%.
US stocks are different from Shanghai stocks. There is no 10% rise limit. In other words, if Pfizer is a bit more aggressive, it may not necessarily return to its previous market value within a day.
Seeing that the stock price of Pfizer Pharmaceuticals rises like a rocket~EbookFREE.me~ Maybe those stockholders and shareholders are not really ignorant, but they need this excuse to make the stock price rise again.
Before the decline, Pfizer Pharmaceuticals had a market value of more than 200 billion U.S. dollars. Later, it was cut to less than 60 billion U.S. dollars. This kind of fearful decline caused Pfizer to panic. It would rather spend a lot of money to engage with Stars. Get in touch.
Everyone now knows that Star Pharma is a hot company, and it can make more money than all pharmaceutical companies in the research and development of general cancer drugs.
In the past, Pfizer Pharmaceuticals considered itself the leading leader in the hospital industry, but now he only dares to be the second, not the first.
Pfizer's purchase of a partnership quota for US$500 million is quite worthwhile.
By the time the market closed, Pfizer Pharmaceuticals had risen by a total of 40% that day, and the market value had regained a hundred billion dollars.
The increased amount alone has already made a lot of money.
Although Pfizer Pharmaceuticals is still only half of what it was at its peak, all shareholders can see that the time when it once again stands at US$200 billion is not far away.
The increase doesn't need to be too large, a 10% increase every day, just seven or eight days.
If Pfizer is making a big profit, then Ito Pharmaceutical is not bad.
Ito Pharmaceuticals belongs to the Ito Group. The market value of Ito Pharmaceuticals alone is not as high as that of Pfizer. At its peak, it was only a little over 100 billion US dollars.
But this time, Ito Pharmaceutical announced to the outside world the exclusive agency rights of Neon Country signed with Star Pharmaceuticals, and the stock price of Ito Pharmaceuticals has also risen.
The increase is far more exaggerated than Pfizer.
On the day of the announcement, Ito Pharmaceutical's stock price returned to its peak.
No, it was another peak, reaching 110 billion US dollars.